8-K: Longeveron Announces 1-for-10 Reverse Stock Split to Regain Nasdaq Compliance

Longeveron Inc. has approved a 1-for-10 reverse stock split to increase its share price and regain compliance with Nasdaq's minimum bid price requirement.

Summary

• Longeveron Inc. has announced a 1-for-10 reverse stock split of its Class A and Class B common stock.
• The reverse split was approved by stockholders on February 21, 2024, and the board of directors finalized the 1-for-10 ratio on March 19, 2024.
• The reverse split will take effect at 11:59 p.m. Eastern Time on March 26, 2024.
• Trading will begin on a split-adjusted basis under the ticker symbol LGVN on March 27, 2024, with a new CUSIP number 54303L 203.
• The primary goal of the reverse split is to increase the per-share trading price to meet Nasdaq's minimum bid price requirement for continued listing.
• Every ten shares of common stock will be converted into one share, with fractional shares rounded up to the nearest whole number.
• The number of outstanding Class A shares will decrease from approximately 10,295,426 to 1,029,543, and Class B shares will decrease from approximately 14,839,993 to 1,484,000.
• The total authorized number of shares will remain unchanged.
• Outstanding warrants and equity awards will be proportionally adjusted to maintain their economic value.
• Stockholders holding shares electronically will have their positions automatically adjusted, while those with physical certificates will receive instructions from the transfer agent.

Sentiment

Score: 3

Explanation: The document indicates a negative situation as the company is forced to do a reverse stock split to maintain its listing. While the company is taking action to address the issue, the underlying problem of a low share price is concerning.

Positives

• The reverse stock split is a strategic move to regain compliance with Nasdaq's minimum bid price requirement, which is crucial for continued listing.
• The proportional adjustment of warrants and equity awards ensures that their economic value is maintained for holders.
• The rounding up of fractional shares is beneficial to shareholders who would otherwise receive less than a full share.

Negatives

• The reverse stock split is a sign that the company's share price has fallen below the Nasdaq minimum bid price requirement.
• The reduction in the number of outstanding shares may be perceived negatively by some investors.

Risks

• The company's share price may continue to be volatile.
• There is no guarantee that the reverse stock split will result in a sustained increase in the share price.
• The company may face challenges in raising additional capital if its stock price remains low.
• The company's ability to continue as a going concern is dependent on its ability to raise additional capital.

Future Outlook

The company expects the reverse stock split to increase its per share trading price and enable it to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. However, there is no guarantee that the reverse stock split will result in a sustained increase in the share price.

Management Comments

• The company's board of directors approved the 1-for-10 reverse stock split.
• Management believes the reverse stock split is necessary to regain compliance with Nasdaq listing requirements.

Industry Context

Reverse stock splits are a common strategy for companies facing delisting from major exchanges due to low share prices. This action is often seen in the biotechnology sector, where companies may experience volatility due to the nature of clinical trials and regulatory approvals.

Comparison to Industry Standards

• Reverse stock splits are a common practice among companies listed on the Nasdaq that are struggling to maintain the minimum bid price of $1.00 per share.
• Other biotechnology companies such as Athersys and Ocugen have also recently implemented reverse stock splits to maintain their Nasdaq listing.
• The 1-for-10 ratio is within the typical range for reverse stock splits, which can vary from 1-for-2 to 1-for-20 or more.

Corporate Governance

Stakeholder Impact

• Shareholders will see a reduction in the number of shares they own, but the value of their holdings should remain relatively the same immediately after the split.
• The reverse stock split is intended to benefit shareholders by maintaining the company's listing on the Nasdaq.

Next Steps

• The company will begin trading on a split-adjusted basis on March 27, 2024.
• Stockholders holding physical certificates will receive instructions from the transfer agent on how to exchange their certificates.

Key Dates

Keywords

reverse stock split, Nasdaq compliance, stock price, LGVN, Longeveron, shareholder, equity awards, warrants, biotechnology